“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
– 芋螺毒液肽及其分子靶标:使用药理学和神经行为学作为发现框架 –
基本信息
- 批准号:10810172
- 负责人:
- 金额:$ 1.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-15 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AchievementAffectAlzheimer&aposs DiseaseAnimalsBasic ScienceBehaviorBiochemicalBiologicalBiological AssayBiological ModelsCalciumChemicalsClinical TrialsCollectionComplexConeConotoxinConsumptionConus VenomConus genusDevelopmentDiagnosticElectrophysiology (science)EpilepsyFDA approvedFishesFunctional disorderGlandGoalsGrantHourHumanIndividualInvestigationIon ChannelIon Channel GatingLaboratoriesLibrariesLigandsLinkMacrophageMethodsMolecularMolecular TargetMusNational Institute of General Medical SciencesNatural ProductsNervous SystemNicotinic ReceptorsPainPathologyPeptidesPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhysiologicalPhysiologyPotassium ChannelProteomicsPurinoceptorRationalizationResourcesRespiratory distressRoleRouteScienceSnail VenomsSnailsSpinal GangliaStructureSystemTherapeuticTimeVenomsVertebratesVoltage-Gated Potassium Channelbasal forebrainbioactive natural productsbiophysical propertiescell typechronic painganglion cellimaging platformimprovedinhibitorinsightmacromoleculemarinemarine natural productneuroethologynovelnovel strategiespathogenpharmacologicprogramsreceptorscreeningspinal cord injury paintooltranscriptomicsvoltage
项目摘要
Project Summary/Abstract
The hundreds of different bioactive components in the venoms of cone snails have demonstrated
extraordinary biomedical potential in the past, including development as an FDA-approved drug. However,
their discovery and characterization is generally limited by the small amounts of venom that are accessible.
Our laboratory has developed a calcium-imaging platform combined with selective pharmacology
(“Constellation Pharmacology”), that when combined with recent technical advances in transcriptomic and
proteomic analysis and electrophysiology (an integrated platform that we call Pharmaconomics) completely
changes the landscape with respect to discovery and characterization of novel venom components. Using
pharmaconomics, one goal is to tightly couple the discovery and biochemical characterization of individual
venom components with the elucidation of the molecular and cellular mechanisms that underlie their biological
activity. The pharmaconomics approach also uncovers how individual components affect physiology at the
system’s and whole animal level. We will use the insights gained from the characterization of bioactive venom
components to rationalize the species-specific behavior and neuroethology of the cone snail and it’s fish prey.
These new tools should allow an unprecedented rate of discovery of novel bioactive cone snail venom
components tightly linked to the elucidation of their molecular targets.
Although the focus of this project is on venom peptides and their molecular targets, the
pharmaconomics approach can be used for elucidating the physiologically-relevant molecular target of any
natural product. Linking the vast chemical diversity of natural products to their cognate macromolecular
receptors should greatly expand the use of natural products as pharmacological tools in basic research, as well
as their therapeutic and other biomedical applications.
项目概要/摘要
锥蜗牛毒液中数百种不同的生物活性成分已被证明
过去具有非凡的生物医学潜力,包括作为 FDA 批准的药物进行开发。
它们的发现和表征通常受到可获取的少量毒液的限制。
我们实验室开发了结合选择性药理学的钙成像平台
(“Constellation Pharmacology”),当与转录组学和
蛋白质组学分析和电生理学(我们称之为药物经济学的综合平台)完全
改变了新毒液成分的发现和表征方面的情况。
药物经济学,一个目标是将个体的发现和生化特征紧密结合起来
毒液成分及其生物学基础的分子和细胞机制的阐明
药理学方法还揭示了各个成分如何影响生理学。
我们将利用从生物活性毒液的表征中获得的见解。
使锥形蜗牛及其鱼类猎物的物种特异性行为和神经行为学合理化的组件。
这些新工具应该能够以前所未有的速度发现新型生物活性锥蜗牛毒液
与其分子靶点的阐明紧密相关的成分。
尽管该项目的重点是毒液肽及其分子靶标,
药理学方法可用于阐明任何药物的生理相关分子靶点
将天然产物的巨大化学多样性与其同源大分子联系起来。
受体应该大大扩展天然产物作为基础研究中药理学工具的使用,以及
作为它们的治疗和其他生物医学应用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3.
- DOI:10.1371/journal.pbio.3002217
- 发表时间:2023-08
- 期刊:
- 影响因子:9.8
- 作者:Hackney, Celeste D.;Salcedo, Paula Florez;Mueller, Emilie;Koch, Thomas Lund;Kjelgaard, Lau R.;Watkins, Maren J.;Zachariassen, Linda S.;Tuelund, Pernille Sonderby;McArthur, Jeffrey K.;Adams, David;Kristensen, Anders;Olivera, Baldomero;Finol-Urdaneta, Rocio;Safavi-Hemami, Helena;Morth, Jens Preben;Ellgaard, Lars
- 通讯作者:Ellgaard, Lars
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BALDOMERO M OLIVERA其他文献
BALDOMERO M OLIVERA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BALDOMERO M OLIVERA', 18)}}的其他基金
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
– 芋螺毒液肽及其分子靶标:使用药理学和神经行为学作为发现框架 –
- 批准号:
10592438 - 财政年份:2022
- 资助金额:
$ 1.08万 - 项目类别:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
– 芋螺毒液肽及其分子靶标:使用药理学和神经行为学作为发现框架 –
- 批准号:
10346236 - 财政年份:2022
- 资助金额:
$ 1.08万 - 项目类别:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
– 芋螺毒液肽及其分子靶标:使用药理学和神经行为学作为发现框架 –
- 批准号:
10798547 - 财政年份:2022
- 资助金额:
$ 1.08万 - 项目类别:
Life history-guided drug discovery from venomous marine snails
以生活史为指导的有毒海洋蜗牛药物发现
- 批准号:
10361532 - 财政年份:2018
- 资助金额:
$ 1.08万 - 项目类别:
Life history-guided drug discovery from venomous marine snails
以生活史为指导的有毒海洋蜗牛药物发现
- 批准号:
9896842 - 财政年份:2018
- 资助金额:
$ 1.08万 - 项目类别:
CONOTOXINS AND HOMERIC NICOTINIC ACETYLCHOLINE RECEPTORS
芋螺毒素和荷马烟碱乙酰胆碱受体
- 批准号:
6610794 - 财政年份:2003
- 资助金额:
$ 1.08万 - 项目类别:
CONANTOKINS: NMDA RECEPTOR SUBTYPES AND EPILEPSY
锥豆素:NMDA 受体亚型与癫痫
- 批准号:
6610790 - 财政年份:2003
- 资助金额:
$ 1.08万 - 项目类别:
相似国自然基金
小胶质细胞特异罕见易感突变介导相分离影响阿尔茨海默病发病风险的机制
- 批准号:82371438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
OATPs介导Aβ/p-Tau转运对阿尔茨海默病病理机制形成及治疗影响的研究
- 批准号:82360734
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超细颗粒物暴露对阿尔茨海默病的影响及其机制研究
- 批准号:82373532
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于个体水平的空气环境暴露组学探讨影响阿尔茨海默病的风险因素
- 批准号:82304102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
利用小鼠模型研究Y染色体丢失对阿尔茨海默病的影响及分子机制
- 批准号:32260148
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Identifying barriers to optimizing data sharing and accelerate discovery in Alzheimer’s disease and related dementia research
识别优化数据共享和加速阿尔茨海默病及相关痴呆症研究发现的障碍
- 批准号:
10568214 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
A mechanistic and dyadic approach to identify how interpersonal conscientiousness supports cognitive health and lowers risk of dementia
采用机械和二元方法来确定人际责任感如何支持认知健康并降低痴呆风险
- 批准号:
10739837 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up
中年痴呆症风险因素的早期预测因素:35 年随访
- 批准号:
10596295 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Pain and Nutrition in Dementia and Alzheimers PANDA
痴呆症和阿尔茨海默病的疼痛和营养 PANDA
- 批准号:
10644355 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
– 芋螺毒液肽及其分子靶标:使用药理学和神经行为学作为发现框架 –
- 批准号:
10592438 - 财政年份:2022
- 资助金额:
$ 1.08万 - 项目类别: